TAE Life Sciences is developing a next-generation boron neutron capture therapy for cancer. After recently introducing Alphabeam, a compact and affordable accelerator-based neutron system suitable ...
and are suitable for boron neutron capture therapy (BNCT). This technique involves injecting a malignant tumour with non-radioactive boron, then bombarding the site with the neutrons, triggering ...